Reports for MYLAN PHARMACEUTICALS ULC
Company Name
MYLAN PHARMACEUTICALS ULC
Totals |
||
Shortage reports |
644 |
|
| Actual shortage: | 11 (2%) | |
| Anticipated shortage: | 2 (0%) | |
| Avoided shortage: | 85 (13%) | |
| Resolved: | 546 (85%) | |
Discontinuation Reports |
234 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 234 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
81 (9%) |
|
Overdue reports |
0 (0%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-04-02 | 2020-07-01 | 110465 |
| MYLAN-VERAPAMIL SR | 120MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-04-02 | 2021-03-09 | 110509 |
| MYLAN-VERAPAMIL SR | 180MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-07-21 | 2021-03-17 | 120686 |
| MYLAN-VERAPAMIL SR | 240MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-07-28 | 2020-12-01 | 121246 |
| MYLAN-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-10-06 | 2022-08-25 | 125767 |
| MYLAN-VERAPAMIL SR | 240MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-01-05 | 2021-03-17 | 130850 |
| MYLAN-GLICLAZIDE MR | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-01-20 | 2021-02-24 | 132033 |
| MYLAN-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-02-09 | 2022-08-25 | 133595 |
| MYLAN-VERAPAMIL SR | 120MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-04-20 | 2021-05-27 | 137769 |
| MYLAN-VERAPAMIL SR | 240MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2023-03-27 | 2023-03-27 | 188108 |
| MYLAN-VERAPAMIL SR | 180MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2023-03-27 | 2024-02-22 | 188111 |
| MYLAN-VERAPAMIL SR | 120MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-08-01 | 2024-02-21 | 200642 |
| MYLAN-NIFEDIPINE EXTENDED RELEASE | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-11-06 | 2023-11-14 | 209413 |
| MYLAN-GLICLAZIDE MR | 30MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-04-01 | 2024-05-17 | 224058 |
| MYLAN-NAPROXEN EC | 375MG | TABLET (ENTERIC-COATED) | Resolved | 2017-04-07 | 2018-07-11 | 5916 |
| MYLAN-NAPROXEN EC | 500MG | TABLET (ENTERIC-COATED) | Resolved | 2017-12-21 | 2018-07-11 | 34097 |
| MYLAN-DIVALPROEX | 500MG | TABLET (ENTERIC-COATED) | Resolved | 2018-10-29 | 2018-12-19 | 65722 |
| MYLAN-DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Avoided shortage | 2018-12-12 | 2019-02-01 | 69423 |
| MYLAN-DIVALPROEX | 500MG | TABLET (ENTERIC-COATED) | Resolved | 2019-01-02 | 2019-01-18 | 70728 |
| MYLAN-DIVALPROEX | 500MG | TABLET (ENTERIC-COATED) | Resolved | 2019-01-21 | 2019-03-06 | 73034 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-07-17 | 2017-07-17 | 16009 |
| MYLAN-OLANZAPINE ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-07-17 | 2017-07-17 | 16012 |
| MYLAN-OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-07-17 | 2017-07-17 | 16015 |
| MYLAN-OLANZAPINE ODT | 20MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-07-17 | 2017-07-17 | 16018 |
| MYLAN-ZOLMITRIPTAN ODT | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-06-06 | 2018-07-04 | 51653 |
| MYLAN-RISPERIDONE ODT | 0.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149759 |
| MYLAN-RISPERIDONE ODT | 1MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149762 |
| MYLAN-RISPERIDONE ODT | 2MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149765 |
| MYLAN-RISPERIDONE ODT | 3MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149768 |
| MYLAN-RISPERIDONE ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149771 |
| MYLAN-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2022-08-25 | 2022-08-25 | 167806 |
| MYLAN-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2022-08-25 | 2022-08-25 | 167819 |
| MYLAN-NAPROXEN EC | 375MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-07-10 | 2018-07-11 | 55130 |
| MYLAN-NAPROXEN EC | 500MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-07-10 | 2018-07-11 | 55141 |
| MYLAN-RABEPRAZOLE | 10MG | TABLET (DELAYED-RELEASE) | Discontinued | 2017-07-17 | 2018-02-15 | 16039 |
| MYLAN-RABEPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Discontinued | 2017-07-17 | 2018-02-15 | 16042 |
| MYLAN-PANTOPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-06-05 | 2018-07-04 | 51513 |
| MYLAN-ESOMEPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Discontinued | 2021-05-17 | 2021-05-17 | 139518 |
| MYLAN-ESOMEPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Discontinued | 2021-05-17 | 2021-05-17 | 139521 |
| MYLAN-MONTELUKAST | 4MG | TABLET (CHEWABLE) | Discontinued | 2017-07-18 | 2017-09-08 | 16138 |